MICAFUNGINA ACCORD 100 mg POWDER FOR CONCENTRATE FOR INFUSION SOLUTION
Ask a doctor about a prescription for MICAFUNGINA ACCORD 100 mg POWDER FOR CONCENTRATE FOR INFUSION SOLUTION
How to use MICAFUNGINA ACCORD 100 mg POWDER FOR CONCENTRATE FOR INFUSION SOLUTION
Introduction
Package Leaflet: Information for the User
Micafungina Accord100 mg powder for concentrate for solution for infusion EFG
micafungina
Read all of this leaflet carefully before you start using this medicine because it contains important information for you.
- Keep this leaflet, you may need to read it again.
- If you have any further questions, ask your doctor or pharmacist.
- If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.
Contents of the pack
- What is Micafungina Accord and what is it used for
- What you need to know before you use Micafungina Accord
- How to use Micafungina Accord
- Possible side effects
- Storage of Micafungina Accord
- Contents of the pack and other information
1. What is Micafungina Accord and what is it used for
This medicine contains the active substance micafungin. Micafungin is an antifungal medicine used to treat infections caused by fungal cells.
Micafungin is used to treat fungal infections caused by fungal cells or yeasts called Candida. Micafungin is effective in treating systemic infections (those that have penetrated the body). It interferes with the production of a part of the fungal cell wall. The fungus needs an intact cell wall to live and grow. Micafungin causes the formation of defects in the fungal cell wall, preventing the fungus from growing and living.
When no other antifungal treatment is available, your doctor prescribes Micafungina in the following circumstances (see section 2):
- To treat a severe fungal infection in adults, adolescents, and children, including newborns, called invasive candidiasis (infection that has penetrated the body).
- To treat adults and adolescents ≥ 16 years with a fungal infection in the esophagus where it is appropriate to apply intravenous treatment.
- To prevent Candida infection in patients undergoing bone marrow transplantation or who are expected to have neutropenia (low levels of neutrophils, a type of white blood cell) for 10 days or more.
2. What you need to know before you use Micafungina Accord
Do not use Micafungina Accord
- if you are allergic to micafungin, to other echinocandins (anidulafungin or caspofungin), or to any of the other components of this medicine (listed in section 6).
Warnings and precautions
Consult your doctor or pharmacist before starting to use micafungin
- if you are allergic to any medicine
- if you have hemolytic anemia (anemia produced by the rupture of red blood cells) or hemolysis (rupture of red blood cells).
- if you have kidney problems (renal failure or abnormal renal function tests). In this case, your doctor may decide to monitor your renal function more closely.
Micafungina can also cause severe skin and mucous membrane inflammation/eruption (Stevens-Johnson syndrome, toxic epidermal necrolysis).
Other medicines and Micafungina Accord
Tell your doctor or pharmacist if you are using, have recently used, or might use any other medicines.
It is especially important that you inform your doctor if you are using amphotericin B desoxycholate or itraconazole (antifungal antibiotics), sirolimus (an immunosuppressant), or nifedipine (a calcium channel blocker used to treat high blood pressure). Your doctor may decide to adjust the dose of these medicines.
Using Micafungina Accord with food and drinks
Since micafungin is administered intravenously (in the vein), there are no restrictions on food or drinks.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medicine.
Micafungina should not be used during pregnancy unless clearly necessary. If you use micafungina, you should not breastfeed.
Driving and using machines
It is unlikely that micafungina will affect your ability to drive or use machines. However, some people may feel dizzy when taking this medicine, and if this happens to you, do not drive or use any machine or tool. Please inform your doctor if you experience any effect that may cause problems for driving or using machinery.
Micafungina Accord contains sodium
This medicine contains less than 1 mmol of sodium (23 mg) per dose; this is essentially "sodium-free".
3. How to use Micafungina Accord
Micafungina must be prepared and administered by a doctor or other healthcare professional.
Micafungina must be administered by slow intravenous infusion (in the vein), once a day. Your doctor will determine the dose of micafungina you will receive each day.
Use in adults, adolescents ≥ 16 years, and elderly patients
- The usual dose for treating an invasive Candida infection is 100 mg per day for patients weighing more than 40 kg, and 2 mg/kg per day for patients weighing 40 kg or less.
- The dose for treating a Candida esophagus infection is 150 mg for patients weighing more than 40 kg, and 3 mg/kg per day for patients weighing 40 kg or less.
- The usual dose for preventing invasive Candida infections is 50 mg per day for patients weighing more than 40 kg, and 1 mg/kg per day for patients weighing 40 kg or less.
Use in children ≥ 4 months of age and adolescents < 16 years
- The usual dose for treating an invasive Candida infection is 100 mg per day for patients weighing more than 40 kg, and 2 mg/kg per day for patients weighing 40 kg or less.
- The usual dose for preventing invasive Candida infections is 50 mg per day for patients weighing more than 40 kg, and 1 mg/kg per day for patients weighing 40 kg or less.
Use in children and newborns < 4 months of age
- The usual dose for treating an invasive Candida infection is 4-10 mg/kg per day.
- The usual dose for preventing invasive Candida infections is 2 mg/kg per day.
If you receive more Micafungina Accord than you should
Your doctor will monitor your response and the state of your disease to determine the necessary dose of micafungina. However, if you are concerned that you have received too much micafungina, consult your doctor or another healthcare professional immediately or call the Toxicology Information Service, phone 91 562 04 20, indicating the medicine and the amount received.
If you miss a dose of Micafungina Accord
Your doctor will monitor your response and the state of your disease to determine the appropriate treatment with micafungina. However, if you are concerned that you have missed a dose of micafungina, contact your doctor or another healthcare professional immediately.
If you have any other questions about the use of this medicine, ask your doctor or pharmacist.
4. Possible side effects
Like all medicines, this medicine can cause side effects, although not everybody gets them.
If you suffer an allergic reaction or a severe skin reaction (e.g., blistering of the skin and peeling of the skin), you should inform your doctor or nurse immediately.
Micafungina can cause these other side effects:
Common (may affect up to 1 in 10 people)
- abnormal blood test results (reduction in the number of white blood cells [leukopenia; neutropenia]); reduction in the number of red blood cells (anemia)
reduction of potassium in blood (hypokalemia); reduction of magnesium in blood (hypomagnesemia); reduction of calcium in blood (hypocalcemia)
- headache
- inflammation of the vein wall (at the injection site)
- nausea (discomfort); vomiting; diarrhea; abdominal pain
- abnormal liver test results (increase in alkaline phosphatase; increase in aspartate aminotransferase; increase in alanine aminotransferase)
- increase in bilirubin in the blood (hyperbilirubinemia)
- rash
- fever
- chills
Uncommon (may affect up to 1 in 100 people)
- abnormal blood test results (reduction in the number of blood cells [pancytopenia]); reduction in the number of platelets (thrombocytopenia); increase in the number of a certain type of white blood cells called eosinophils; reduction of albumin in blood (hypoalbuminemia)
- hypersensitivity
- increased sweating
- reduction of sodium in blood (hyponatremia); increase of potassium in blood (hyperkalemia); reduction of phosphates in blood (hypophosphatemia); anorexia (eating disorder)
- insomnia (difficulty sleeping); anxiety; confusion
- drowsiness (somnolence); tremors; dizziness
- increased heart rate; stronger heartbeat; irregular heartbeat
- high or low blood pressure; flushing
- shortness of breath
- indigestion; constipation
- liver failure; increase in liver enzymes (gamma-glutamyltransferase); jaundice (the skin or the white of the eyes turn yellow due to liver or blood problems); reduction of bile reaching the intestine (cholestasis); increase in liver size; liver inflammation
- rash with itching (urticaria); itching; flushing (erythema)
- abnormal kidney function tests (increase in creatinine in blood; increase in urea in blood); worsening of kidney failure
- increase in an enzyme called lactate dehydrogenase
- clot formation at the injection site; inflammation at the injection site; pain at the injection site; fluid accumulation in the body
Rare (may affect up to 1 in 1,000 people)
- anemia produced by the rupture of red blood cells (hemolytic anemia), rupture of red blood cells (hemolysis)
Not known (frequency cannot be estimated from the available data)
- blood coagulation disorders
- shock (allergic)
- liver cell damage including death
- kidney damage; acute kidney failure
Other side effects in children and adolescents
The following reactions have been described more frequently in pediatric patients than in adults:
Common (may affect up to 1 in 10 people)
- reduction of platelets in blood (thrombocytopenia)
- increased heart rate (tachycardia)
- high or low blood pressure
- increase in bilirubin in blood (hyperbilirubinemia); increase in liver size
- acute kidney failure; increase in urea in blood
Reporting of side effects
If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly through the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.
5. Storage of Micafungina Accord
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the vial and on the carton. The expiry date is the last day of the month stated.
The intact vial (unopened) does not require special storage conditions.
The reconstituted concentrate and the diluted solution for infusion must be used immediately, because it does not contain preservatives to prevent bacterial contamination. Only a healthcare professional who has been properly trained and has read the instructions completely can prepare this medicine for use.
Do not use the diluted solution for infusion if you notice that it is cloudy or if a precipitate has formed.
To protect the bottle/bag containing the diluted solution for infusion from light, it should be placed in an opaque bag with a seal.
The vial is for single use. Therefore, the reconstituted concentrate that is not used must be discarded immediately.
6. Contents of the pack and other information
Composition of Micafungina Accord
- The active substance is micafungin (as sodium salt). 1 vial contains 100 mg of micafungin (as sodium salt).
- The other ingredients are lactose monohydrate, citric acid, and sodium hydroxide.
Appearance and pack contents
Micafungina Accord 100 mg powder for concentrate for solution for infusion is a white or off-white compact powder.
Marketing authorisation holder
Accord Healthcare, S.L.U.
World Trade Center
Moll de Barcelona, s/n.
Edifici Est 6ª planta 08039 - Barcelona
Spain
Manufacturer
PharmIdea SIA
Rupnicu Street 4, Olaine 2114,
Latvia
O
Lyocontract GmbH
Pulverwiese 1, 38871 Ilsenburg,
Germany
O
Accord Healthcare Polska Sp. Z.o.o.
Ul. Tasmowa 7, Entrance B, 6th floor
Marynarska Business Park, Warsaw,
Poland
O
Accord Healthcare B.V.
Winthontlaan 200, Utrecht,
Netherlands
Date of last revision of this leaflet: March 2024
____________________________________________________________________________
This information is intended only for healthcare professionals:
Micafungina should not be mixed or infused simultaneously with other medicines except those mentioned below. Micafungina is reconstituted and diluted using aseptic techniques at room temperature, as indicated below:
- The plastic cap should be removed from the vial and the stopper should be disinfected with alcohol.
- 5 ml of sodium chloride 9 mg/ml (0.9%) solution for infusion or glucose 50 mg/ml (5%) solution for infusion (taken from a 100 ml bottle/bag) should be slowly and aseptically injected into each vial along the inner wall. Although the concentrate will foam, care should be taken to minimize the amount of foam generated. A sufficient number of micafungina vials should be reconstituted to obtain the necessary dose in mg (see the table below).
- The vial should be gently rotated. IT SHOULD NOT BE SHAKEN. The powder will dissolve completely. The concentrate should be used immediately. The vial is for single use. Therefore, the reconstituted concentrate that is not used should be discarded immediately.
- All the reconstituted concentrate should be withdrawn from each vial and returned to the infusion bottle/bag from which it was initially taken. The diluted solution for infusion should be used immediately. It has been shown that the chemical and physical stability allows the use of the medicine for 96 hours, when stored at 25°C, provided it is protected from light, and the dilution is performed as described above.
- The infusion bottle/bag should be carefully inverted to disperse the diluted solution but SHOULD NOT BE SHAKEN, to avoid foam formation. The solution should not be used if it is cloudy or if a precipitate has formed.
- The bottle/bag containing the diluted solution for infusion should be placed in an opaque bag with a seal to protect it from light.
Preparation of the infusion solution
Dose (mg) | Micafungina vial to use (mg/vial) | Volume of sodium chloride (0.9%) or glucose (5%) to add to each vial | Volume (concentration) of reconstituted powder | Standard infusion (up to 100 ml) Final concentration |
50 | 1 x 50 | 5 ml | approx. 5 ml (10 mg/ml) | 0.5 mg/ml |
100 | 1 x 100 | 5 ml | approx. 5 ml (20 mg/ml) | 1.0 mg/ml |
150 | 1 x 100 + 1 x 50 | 5 ml | approx. 10 ml | 1.5 mg/ml |
200 | 2 x 100 | 5 ml | approx. 10 ml | 2.0 mg/ml |
- Country of registration
- Active substance
- Prescription requiredYes
- Manufacturer
- This information is for reference only and does not constitute medical advice. Always consult a licensed doctor before taking any medication. Oladoctor is not responsible for medical decisions based on this content.
- Alternatives to MICAFUNGINA ACCORD 100 mg POWDER FOR CONCENTRATE FOR INFUSION SOLUTIONDosage form: INJECTABLE PERFUSION, 50 mgActive substance: micafunginManufacturer: Accord Healthcare S.L.U.Prescription requiredDosage form: INJECTABLE PERFUSION, 100 mgActive substance: micafunginManufacturer: Accord Healthcare S.L.U.Prescription requiredDosage form: INJECTABLE PERFUSION, 50 mgActive substance: micafunginManufacturer: Accord Healthcare S.L.U.Prescription required
Alternatives to MICAFUNGINA ACCORD 100 mg POWDER FOR CONCENTRATE FOR INFUSION SOLUTION in other countries
The best alternatives with the same active ingredient and therapeutic effect.
Alternative to MICAFUNGINA ACCORD 100 mg POWDER FOR CONCENTRATE FOR INFUSION SOLUTION in Poland
Alternative to MICAFUNGINA ACCORD 100 mg POWDER FOR CONCENTRATE FOR INFUSION SOLUTION in Ukraine
Online doctors for MICAFUNGINA ACCORD 100 mg POWDER FOR CONCENTRATE FOR INFUSION SOLUTION
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for MICAFUNGINA ACCORD 100 mg POWDER FOR CONCENTRATE FOR INFUSION SOLUTION – subject to medical assessment and local rules.
Get updates and exclusive offers
Be the first to know about new services, marketplace updates, and subscriber-only promos.
